GeranylGeranylAcetone as prevention for postoperative Atrial Fibrillation (GENIALITY)

Status

Not yet recruiting

Phases

Phase 2

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2024-514743-28-00

Acronym

2024-514743-28-00

Enrollment

146

Registered

2024-09-30

Start date

Unknown

Completion date

Unknown

Last updated

2025-01-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative Atrial Fibrillation

Brief summary

Assessment of Postoperative atrial fibrillation incidence, by Holter monitoring

Detailed description

The secondary trial endpoints are assessments of activation of HSPs by biochemical analysis and microscopic imaging; in blood, atrial tissue and epicardial adipose tissue

Interventions

DRUGMedium-chain triglycerides (Miglyol 812N)

DRUGCAS Number: 73398-61-5

DRUGTEPRENONE

Eligibility

Sex/Gender

All

Age

18 Years to 64 Years

Design outcomes

Primary

Measure	Time frame
Assessment of Postoperative atrial fibrillation incidence, by Holter monitoring	—

Secondary

Measure	Time frame
The secondary trial endpoints are assessments of activation of HSPs by biochemical analysis and microscopic imaging; in blood, atrial tissue and epicardial adipose tissue	—

Countries

Netherlands

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 5, 2026